44 related articles for article (PubMed ID: 22495633)
1. Vaginal delivery of protein drugs in rats by gene-transformed Lactococcus lactis.
Kaushal G; Shao J
Drug Discov Ther; 2009 Oct; 3(5):228-33. PubMed ID: 22495633
[TBL] [Abstract][Full Text] [Related]
2. Oral delivery of beta-lactamase by Lactococcus lactis subsp. lactis transformed with Plasmid ss80.
Kaushal G; Shao J
Int J Pharm; 2006 Apr; 312(1-2):90-5. PubMed ID: 16451824
[TBL] [Abstract][Full Text] [Related]
3. Delivery of TEM beta-lactamase by gene-transformed Lactococcus lactis subsp. lactis through cervical cell monolayer.
Kaushal G; Trombetta L; Ochs RS; Shao J
Int J Pharm; 2006 Apr; 313(1-2):29-35. PubMed ID: 16488095
[TBL] [Abstract][Full Text] [Related]
4. Genetically engineered normal flora for oral polypeptide delivery: dose-absorption response.
Kaushal G; Shao J
J Pharm Sci; 2009 Aug; 98(8):2573-80. PubMed ID: 19266563
[TBL] [Abstract][Full Text] [Related]
5. Normal flora: living vehicles for non-invasive protein drug delivery.
Shao J; Kaushal G
Int J Pharm; 2004 Nov; 286(1-2):117-24. PubMed ID: 15501008
[TBL] [Abstract][Full Text] [Related]
6. Lactobacillus plantarum for oral peptide delivery.
Oh Y; Varmanen P; Han XY; Bennett G; Xu Z; Lu T; Palva A
Oral Microbiol Immunol; 2007 Apr; 22(2):140-4. PubMed ID: 17311639
[TBL] [Abstract][Full Text] [Related]
7. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.
Foligne B; Dessein R; Marceau M; Poiret S; Chamaillard M; Pot B; Simonet M; Daniel C
Gastroenterology; 2007 Sep; 133(3):862-74. PubMed ID: 17678918
[TBL] [Abstract][Full Text] [Related]
8. Display of heterologous proteins on the surface of Lactococcus lactis using the H and W domain of PrtB from Lactobacillus delburueckii subsp. bulgaricus as an anchoring matrix.
Kim TW; Igimi S; Kajikawa A; Kim HY
J Appl Microbiol; 2008 Jun; 104(6):1636-43. PubMed ID: 18298534
[TBL] [Abstract][Full Text] [Related]
9. [Construction and property study of recombinant Lactococcus lactis with non-fusion expressing of beta-galactosidase].
Wang C; Liu HC; Pei XF; Yu Q; Zhang CW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):29-32. PubMed ID: 19292038
[TBL] [Abstract][Full Text] [Related]
10. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
11. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of protein drugs: III. In vivo oral absorption study.
Rao SV; Yajurvedi K; Shao J
Int J Pharm; 2008 Oct; 362(1-2):16-9. PubMed ID: 18650037
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice.
Jing H; Yong L; Haiyan L; Yanjun M; Yun X; Yu Z; Taiming L; Rongyue C; Liang J; Jie W; Li Z; Jingjing L
Vaccine; 2011 May; 29(24):4102-9. PubMed ID: 21497632
[TBL] [Abstract][Full Text] [Related]
13. Lactococcus lactis subspecies lactis also causes white muscle disease in farmed giant freshwater prawns Macrobrachium rosenbergii.
Wang PC; Lin YD; Liaw LL; Chern RS; Chen SC
Dis Aquat Organ; 2008 Mar; 79(1):9-17. PubMed ID: 18429437
[TBL] [Abstract][Full Text] [Related]
14. Safety and risk assessment of the genetically modified Lactococci on rats intestinal bacterial flora.
Lee KC; Liu CF; Lin TH; Pan TM
Int J Food Microbiol; 2010 Aug; 142(1-2):164-9. PubMed ID: 20619909
[TBL] [Abstract][Full Text] [Related]
15. Cell surface display system for Lactococcus lactis: a novel development for oral vaccine.
Raha AR; Varma NR; Yusoff K; Ross E; Foo HL
Appl Microbiol Biotechnol; 2005 Jul; 68(1):75-81. PubMed ID: 15635459
[TBL] [Abstract][Full Text] [Related]
16. Lactococcus lactis: from the dairy industry to antigen and therapeutic protein delivery.
Bahey-El-Din M; Gahan CG
Discov Med; 2010 May; 9(48):455-61. PubMed ID: 20515614
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization.
Frossard CP; Steidler L; Eigenmann PA
J Allergy Clin Immunol; 2007 Apr; 119(4):952-9. PubMed ID: 17316776
[TBL] [Abstract][Full Text] [Related]
18. Development of a recombinant ureolytic Lactococcus lactis for urea removal.
Zhang S; Li D; Tian K; Bai Y; Zhang H; Song C; Qiao M; Kong D; Yu Y
Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(6):227-34. PubMed ID: 19900066
[TBL] [Abstract][Full Text] [Related]
19. Expression of a beta-galactosidase gene from Clostridium acetobutylicum in Lactococcus lactis subsp. lactis.
Pillidge CJ; Pearce LE
J Appl Bacteriol; 1991 Jul; 71(1):78-85. PubMed ID: 1910034
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of recombinant Lactococcus lactis expressing bovine beta-lactoglobulin partially prevents mice from sensitization.
Adel-Patient K; Ah-Leung S; Creminon C; Nouaille S; Chatel JM; Langella P; Wal JM
Clin Exp Allergy; 2005 Apr; 35(4):539-46. PubMed ID: 15836765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
